ADUS · Addus Homecare Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.42B | $1.15B | $1.06B | $951.12M | $864.50M | $764.77M |
| Cost of Revenue | $960.66M | $779.58M | $718.77M | $651.38M | $594.65M | $538.54M |
| Gross Profit | $461.87M | $375.02M | $339.88M | $299.74M | $269.85M | $226.24M |
| R&D | - | - | - | - | - | - |
| SG&A | $306.85M | $258.80M | $234.79M | $216.94M | $189.42M | $169.68M |
| Total Operating Expenses | $323.26M | $272.33M | $248.92M | $231.00M | $203.91M | $181.73M |
| D&A | $16.41M | $13.53M | $14.13M | $14.06M | $14.49M | $12.05M |
| Operating Income | $138.62M | $102.69M | $90.96M | $68.74M | $65.94M | $44.51M |
| Interest Expense | $13.61M | $7.73M | $11.11M | $8.91M | $5.81M | $3.19M |
| Income Tax | $31.54M | $25.75M | $18.81M | $14.15M | $15.27M | $8.81M |
| Net Income | $95.91M | $73.60M | $62.52M | $46.02M | $45.13M | $33.13M |
| EPS - Basic | $5.31 | $4.33 | $3.91 | $2.90 | $2.87 | $2.12 |
| EPS - Diluted | $5.22 | $4.23 | $3.83 | $2.84 | $2.81 | $2.08 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $81.62M | $98.91M | $64.79M | $79.96M | $168.90M | $145.08M |
| Accounts Receivable | $151.69M | $122.88M | $115.50M | $125.50M | $136.96M | $132.65M |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $16.83M | $27.18M | $26.18M | $22.09M | $19.36M | $23.70M |
| Current Assets | $269.49M | $260.38M | $200.00M | $222.81M | $324.34M | $287.70M |
| Total Assets | $1.44B | $1.41B | $1.02B | $937.99M | $947.59M | $892.58M |
| Current Liabilities | $149.49M | $155.87M | $145.12M | $131.15M | $117.69M | $143.90M |
| Long-term Debt | $120.96M | $218.44M | $124.13M | $131.77M | $220.91M | $193.90M |
| Total Liabilities | $352.00M | $442.14M | $317.73M | $304.45M | $373.24M | $373.91M |
| Stockholders' Equity | $1.09B | $970.49M | $706.69M | $633.54M | $574.34M | $518.68M |
| Retained Earnings | $472.34M | $376.43M | $302.83M | $240.32M | $194.29M | $149.16M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $111.51M | $116.43M | $112.25M | $105.11M | $39.49M | $109.41M |
| Investing Cash Flow | ($32.50M) | ($354.61M) | ($119.24M) | ($106.59M) | ($42.02M) | ($214.24M) |
| Financing Cash Flow | ($96.30M) | $272.30M | ($8.18M) | ($87.45M) | $26.34M | $138.19M |
| CapEx | $7.72M | $6.05M | $9.45M | $8.30M | $4.64M | $6.83M |
| Free Cash Flow | $103.79M | $110.38M | $102.79M | $96.81M | $34.84M | $102.58M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 32.5% | 32.5% | 32.1% | 31.5% | 31.2% | 29.6% |
| Operating margin | 9.7% | 8.9% | 8.6% | 7.2% | 7.6% | 5.8% |
| EBITDA margin | 10.9% | 10.1% | 9.9% | 8.7% | 9.3% | 7.4% |
| Net margin | 6.7% | 6.4% | 5.9% | 4.8% | 5.2% | 4.3% |
| Free cash flow margin | 7.3% | 9.6% | 9.7% | 10.2% | 4.0% | 13.4% |
| FCF / Net income | 1.08 | 1.50 | 1.64 | 2.10 | 0.77 | 3.10 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 21.6% | 22.4% | 22.2% | 22.8% | 21.9% | 22.2% |
| Effective tax rate | 24.7% | 25.9% | 23.1% | 23.5% | 25.3% | 21.0% |
| Return on assets | 6.7% | 5.2% | 6.1% | 4.9% | 4.8% | 3.7% |
| Return on equity | 8.8% | 7.6% | 8.8% | 7.3% | 7.9% | 6.4% |
| Return on invested capital | 8.6% | 6.4% | 8.4% | 6.9% | 6.2% | 4.9% |
| Liquidity | ||||||
| Current ratio | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 |
| Quick ratio | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 |
| Cash ratio | 0.55 | 0.63 | 0.45 | 0.61 | 1.44 | 1.01 |
| Leverage | ||||||
| Debt / Equity | 0.11 | 0.23 | 0.18 | 0.21 | 0.38 | 0.37 |
| Debt / Assets | 0.08 | 0.15 | 0.12 | 0.14 | 0.23 | 0.22 |
| Debt / EBITDA | 0.78 | 1.88 | 1.18 | 1.59 | 2.75 | 3.43 |
| Interest coverage | 10.2x | 13.3x | 8.2x | 7.7x | 11.4x | 14.0x |
| Equity multiplier | 1.32 | 1.46 | 1.45 | 1.48 | 1.65 | 1.72 |
| Liabilities / Assets | 0.24 | 0.31 | 0.31 | 0.32 | 0.39 | 0.42 |
| Efficiency | ||||||
| Asset turnover | 0.99 | 0.82 | 1.03 | 1.01 | 0.91 | 0.86 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 39d | 39d | 40d | 48d | 58d | 63d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | 6d | 13d | 13d | 12d | 12d | 16d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 20.6x | 29.6x | 24.2x | 35.0x | 33.3x | 56.3x |
| P / B | 1.8x | 2.2x | 2.1x | 2.5x | 2.6x | 3.6x |
| P / S | 1.4x | 1.9x | 1.4x | 1.7x | 1.7x | 2.4x |
| EV / EBITDA | 13.0x | 19.8x | 15.0x | 20.1x | 19.3x | 33.9x |
| Growth | ||||||
| Revenue growth (YoY) | 23.2% | 9.1% | 11.3% | 10.0% | 13.0% | 17.9% |
| Revenue CAGR (3y) | 14.4% | 10.1% | 11.4% | 13.6% | 29.2% | - |
| Revenue CAGR (5y) | 13.2% | 12.2% | 21.4% | - | - | - |
| Gross profit growth (YoY) | 23.2% | 10.3% | 13.4% | 11.1% | 19.3% | 26.2% |
| Operating income growth (YoY) | 35.0% | 12.9% | 32.3% | 4.2% | 48.1% | 28.1% |
| Net income growth (YoY) | 30.3% | 17.7% | 35.8% | 2.0% | 36.2% | 31.3% |
| EPS growth (YoY) | 23.4% | 10.4% | 34.9% | 1.1% | 35.1% | 17.5% |
| EPS CAGR (3y) | 22.5% | 14.6% | 22.6% | 17.1% | 25.8% | 21.1% |
| EPS CAGR (5y) | 20.2% | 19.0% | 22.1% | 19.4% | 21.5% | 14.9% |
| FCF growth (YoY) | -6.0% | 7.4% | 6.2% | 177.8% | -66.0% | 1286.6% |
| FCF CAGR (5y) | 0.2% | 71.7% | 29.8% | - | - | 122.2% |
| Book value growth (YoY) | 11.8% | 37.3% | 11.5% | 10.3% | 10.7% | 9.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$2.27B totalPersonal Care$1.09B · 48.0%
Personal Care Segment$553.48M · 24.4%
Hospice$262.54M · 11.6%
Hospice Segment$244.34M · 10.8%
Home Health$70.77M · 3.1%
Home Health Segment$47.70M · 2.1%
Geographic
$1.22B totalIL$458.83M · 37.6%
All Other States$295.09M · 24.2%
TX$216.71M · 17.8%
NM$118.59M · 9.7%
OH$101.83M · 8.4%
TN$28.21M · 2.3%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
2.92
Safe
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
7/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Home Health Care Services
Comparing Addus HomeCare Corp against the 5 most active filers in the same SIC group.